Zapraszamy do pobrania materiałów wypracowanych w ramach projektu EUnetHTA JA3:
- Raport dot. brolucizumabu w AMD (Brolucizumab for the treatment of adults with neovascular (wet) age-related macular degeneration (AMD))
- Raport dot. sotagliflozyny w cukrzycy (Sotagliflozin for adult patients with Type 1 Diabetes Mellitus who have inadequate blood glucose control using insulin or insulin analogues)
- EUnetHTA Rolling Collaborative Review (RCR22) Authoring Team. Ivermectin for the treatment of COVID-19. Diemen (The Netherlands): EUnetHTA; 2021. [date of citation]. 41 pages. Report No.: RCR22, V1.0. Available from: https //www.eunethta.eu. – https://www.eunethta.eu/rcr22/
- EUnetHTA Rolling Collaborative Review (RCR22) Authoring Team. Ivermectin for the treatment of COVID-19. Diemen (The Netherlands): EUnetHTA; 2021. 42 pages. Report No.: RCR22, V2.0. Available from: https //www.eunethta.eu. – https://www.eunethta.eu/rcr22/
- EUnetHTA Rolling Collaborative Review (RCR22) Authoring Team. Ivermectin for the treatment of COVID-19. Diemen (The Netherlands): EUnetHTA; 2021. 45 pages. Report No.: RCR22, V3.0. Available from: https //www.eunethta.eu. – https://www.eunethta.eu/rcr22/
- EUnetHTA Rolling Collaborative Review (RCR22) Authoring Team. Ivermectin for the treatment of COVID-19. Diemen (The Netherlands): EUnetHTA; 2021. 56 pages. Report No.: RCR22, V4.0. Available from: https //www.eunethta.eu. – https://www.eunethta.eu/rcr22/
- EUnetHTA Rolling Collaborative Review (RCR22) Authoring Team. Ivermectin for the treatment of COVID-19. Diemen (The Netherlands): EUnetHTA; 2021. 47 pages. Report No.: RCR22, V5.0. Available from: https //www.eunethta.eu. – https://www.eunethta.eu/rcr22/
- EUnetHTA Rolling Collaborative Review (RCR22) Authoring Team. Ivermectin for the treatment of COVID-19. Diemen (The Netherlands): EUnetHTA; 2021. 51 pages. Report No.: RCR22, V6.0. Available from: https //www.eunethta.eu. – https://www.eunethta.eu/rcr22/
- EUnetHTA Rolling Collaborative Review (RCR22) Authoring Team. Ivermectin for the treatment of COVID-19. Diemen (The Netherlands): EUnetHTA; 2021. 49 pages. Report No.: RCR22, V7.0. Available from: https //www.eunethta.eu. – https://www.eunethta.eu/rcr22/
- EUnetHTA Rolling Collaborative Review (RCR22) Authoring Team. Ivermectin for the treatment of COVID-19. Diemen (The Netherlands): EUnetHTA; 2021. 47 pages. Report No.: RCR22, V8.0. Available from: https //www.eunethta.eu. – https://www.eunethta.eu/rcr22/
- EUnetHTA Rolling Collaborative Review (RCR22) Authoring Team. Ivermectin for the treatment of COVID-19. Diemen (The Netherlands): EUnetHTA; 2021. 47 pages. Report No.: RCR22, V9.0. Available from: https //www.eunethta.eu. – https://www.eunethta.eu/rcr22/
- EUnetHTA PTJA17. Authoring Team. Elivaldogene autotemcel (eli-cel) for the treatment of cerebral adrenoleukodystrophy (CALD). Joint Assessment. Diemen (The Netherlands): EUnetHTA; 2021. [date of citation]. 73 pages. Report No.: PTJA17. Available from: https //www.eunethta.eu – https://www.eunethta.eu/wp-content/uploads/2021/09/PTJA17-Eli-cel-final-assessment-report-v2.0.pdf?x69613